Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1260092-44-1
1365655-91-9
756525-91-4
882847-13-4
1347750-75-7
1347750-78-0
1027371-75-0 | 2,5-Dioxopyrrolidin-1-yl 3-methoxypropanoate | AA019E89 | MFCD20229579
2182601-79-0 | Bis(m-peg4)-n-oh | AA019EDB | MFCD31561147
1998119-13-3 | Cy7 alkyne | AA019EG5 | MFCD31580105
112101-60-7 | Methyl 4-oxo-4,5,6,7-tetrahydrobenzo[b]thiophene-5-carboxylate | AA019EJS | MFCD00137807
1027616-32-5 | tert-butyl 4-(5-iodopyrimidin-2-yl)piperazine-1-carboxylate | AA019END | MFCD11977095
60077-57-8 | Methyl 4-hydroxybenzofuran-5-carboxylate | AA019EQD | MFCD20528088
1243657-78-4 | (3E)-3-[(1-methylindol-3-yl)methylidene]-1H-pyrrolo[3,2-b]pyridin-2-one | AA019ETB | MFCD22631496
29668-57-3 | N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide | AA019EWP | MFCD14870981
866323-86-6 | (E)-Methyl 3-(3-(N-phenylsulfamoyl)phenyl)acrylate | AA019EZR | MFCD20526565
83207-58-3 | Astragaloside A | AA019FUC | MFCD16036240